Catalent Inc (CTLT)

109.79 +1.18  +1.09% NYSE Jun 21, 16:59 USD
View Full Chart
Price Chart
View All CTLT News


View All Events


Date Type Description
08/31/2021 Earnings Results Q4 2021 Earnings Results
08/31/2021 08:15 EST Earnings Calls Q4 2021 Earnings Call
05/04/2021 Earnings Results Q3 2021 Earnings Results
05/04/2021 08:15 EST Earnings Calls Q3 2021 Earnings Call
02/02/2021 Earnings Results Q2 2021 Earnings Results
02/02/2021 08:15 EST Earnings Calls Q2 2021 Earnings Call
11/03/2020 Earnings Results Q1 2021 Earnings Results
11/03/2020 08:15 EST Earnings Calls Q1 2021 Earnings Call
10/29/2020 08:00 EST AGM 2020 Annual General Meeting
08/31/2020 08:15 EST Earnings Calls Q4 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Catalent Inc is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Aug. 31, 2021
  • Last Earnings Release: May. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
PBE Invesco Dynamic Biotech & Genome ETF 4.94%
IHE iShares US Pharmaceuticals ETF 4.43%
PPH VanEck Vectors Pharmaceutical ETF 4.26%
XPH SPDR® S&P Pharmaceuticals ETF 4.19%
JGMCX Janus Henderson Triton C 2.74%
APDMX Artisan Mid Cap Advisor 2.42%
PTH Invesco DWA Healthcare Momentum ETF 2.33%
RRMGX T. Rowe Price Mid-Cap Growth R 2.08%
PMEGX T. Rowe Price Instl Mid-Cap Equity Gr 2.07%
FGSRX Franklin Growth R 1.58%
MEFNX MassMutual Mid Cap Growth R3 1.55%
BBMC JPMorgan BetaBuilders US Mid Cap Eq ETF 0.55%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.